Pneumocystis jirovecii pneumonia prophylaxis during temozolomide treatment for high-grade gliomas

被引：25

作者：

De Vos, Filip Y. ^{[1
]}

Gijtenbeek, Johanna M. ^{[2
]}

Bleeker-Rovers, Chantal P. ^{[3
]}

van Herpen, Carla M. ^{[4
]}

机构：

[1] Univ Med Ctr Utrecht, Dept Med Oncol, NL-3508 GA Utrecht, Netherlands

[2] Radboud Univ Nijmegen, Med Ctr, Dept Neurooncol, NL-6500 HB Nijmegen, Netherlands

[3] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med Infect Dis, NL-6500 HB Nijmegen, Netherlands

[4] Radboud Univ Nijmegen, Med Ctr, Dept Med Oncol, NL-6500 HB Nijmegen, Netherlands

来源：

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY | 2013年 / 85卷 / 03期

关键词：

Pneumocystis jirovecii; Prophylaxis; Temozolomide; High-grade glioma; DOSE-DENSE TEMOZOLOMIDE; HIV-INFECTED PATIENTS; NECROSIS-FACTOR-ALPHA; REGULATORY T-CELLS; CARINII-PNEUMONIA; AEROSOLIZED PENTAMIDINE; TRIMETHOPRIM-SULFAMETHOXAZOLE; DAPSONE-PYRIMETHAMINE; RANDOMIZED-TRIAL; IMMUNOCOMPROMISED PATIENTS;

D O I：

10.1016/j.critrevonc.2012.08.002

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

High-grade glioma patients receiving concomitant chemoradiotherapy with temozolomide 75 mg/m(2) during six to seven weeks or dose-dense temozolomide regimens especially in combination with chronic use of corticosteroids have a high risk for developing Pneumocystis jirovecii pneumonia. In this review, we define risk groups and propose a guideline for prophylaxis using risk stratification. (c) 2012 Elsevier Ireland Ltd. All rights reserved.

引用

页码：373 / 382

页数：10

共 105 条

[1] Efficacy of protracted dose-dense temozolomide in patients with recurrent high-grade glioma [J].

Abacioglu, Ufuk ;

Caglar, Hale B. ;

Yumuk, Perran F. ;

Akgun, Zuleyha ;

Atasoy, Beste M. ;

Sengoz, Meric .

JOURNAL OF NEURO-ONCOLOGY, 2011, 103 (03) :585-593

[2]

[Anonymous], 2011, SEER CANC STAT REV 1

[3]

[Anonymous], COCHRANE DATABASE SY

[4] AEROSOLIZED PENTAMIDINE, COTRIMOXAZOLE AND DAPSONE PYRIMETHAMINE FOR PRIMARY PROPHYLAXIS OF PNEUMOCYSTIS-CARINII PNEUMONIA AND TOXOPLASMIC ENCEPHALITIS [J].

ANTINORI, A ;

MURRI, R ;

AMMASSARI, A ;

DELUCA, A ;

LANZALONE, A ;

CINGOLANI, A ;

DAMIANO, F ;

MAIURO, G ;

VECCHIET, J ;

SCOPPETTUOLO, G ;

TAMBURRINI, E ;

ORTONA, L .

AIDS, 1995, 9 (12) :1343-1350

[5] Antiparasitic agent atovaquone [J].

Baggish, AL ;

Hill, DR .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (05) :1163-1173

[6]

Barbounis V, 2005, ANTICANCER RES, V25, P651

[7] Extended-schedule dose-dense temozolomide in refractory gliomas [J].

Berrocal, A. ;

Perez Segura, P. ;

Gil, M. ;

Balana, C. ;

Garcia Lopez, J. ;

Yaya, R. ;

Rodriguez, J. ;

Reynes, G. ;

Gallego, O. ;

Iglesias, L. .

JOURNAL OF NEURO-ONCOLOGY, 2010, 96 (03) :417-422

[8]

BLUM RN, 1992, J ACQ IMMUN DEF SYND, V5, P341

[9] GLUCOCORTICOID THERAPY FOR IMMUNE-MEDIATED DISEASES - BASIC AND CLINICAL CORRELATES [J].

BOUMPAS, DT ;

CHROUSOS, GP ;

WILDER, RL ;

CUPPS, TR ;

BALOW, JE .

ANNALS OF INTERNAL MEDICINE, 1993, 119 (12) :1198-1208

[10] A RANDOMIZED TRIAL OF 3 ANTIPNEUMOCYSTIS AGENTS IN PATIENTS WITH ADVANCED HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION [J].

BOZZETTE, SA ;

FINKELSTEIN, DM ;

SPECTOR, SA ;

FRAME, P ;

POWDERLY, WG ;

HE, WL ;

PHILLIPS, L ;

CRAVEN, D ;

VANDERHORST, C ;

FEINBERG, J .

NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (11) :693-699

← 1 2 3 4 5 6 7 8 9 10 →